The North America Lactase Market would witness market growth of 5.9% CAGR during the forecast period (2022-2028).
Premature babies may experience developmental lactose intolerance, which often gets better quickly. A very uncommon genetic disease known as congenital lactose intolerance occurs when there is little to no lactase production from birth. Although frequency rises with age, primary lactose intolerance often manifests in late adolescence or early adulthood. Additionally, lactase deficiency leads to lactose intolerance, which can be hereditary (primary congenital alactasia and primary hypolactasia) or caused by the environment (acquired or secondary hypolactasia).
Insufficient lactase levels in the duodenum's lining are the root cause of symptoms in both situations. In the lack of lactase, the disaccharide molecule lactose, which is present in milk and other dairy products, travels intact into the colon because it cannot be absorbed through the small intestinal wall into the circulation.
Colonic bacteria can metabolize lactose, and the fermentation produces a lot of gas (usually a mixture of carbon dioxide, hydrogen, and methane), which causes different abdominal symptoms. Additionally, because of the unabsorbed carbohydrates and fermentation byproducts, the colon's osmotic pressure is elevated, which results in a greater water flow into the bowels.
Lactose intolerance is rising in North America, raising the demand for dairy products lacking lactose. Consumers in North America, particularly in the United States, are well aware of the lactose intolerance condition. As a result, the demand for dairy products in the country that don't contain lactose is rising. The FDA's judgments about food standards and labeling substantially impact every dairy product, regardless of whether it is currently on the market, in development, or exists in the mind of an innovator working with cutting-edge food ingredients. The American government has established several requirements for lactose-free dairy ingredients. Additionally, the region's consumers have a high level of disposable money, making lactose-free dairy products accessible to them. Due to this, North America's lactase market would expand.
The US market dominated the North America Lactase Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $87,108 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.4% during (2022 - 2028).
Based on Application, the market is segmented into Food & Beverages and Pharmaceutical Products & Dietary Supplements. Based on Food & Beverages Type, the market is segmented into Milk, Yogurt, Cheese, Ice cream and Others. Based on Source, the market is segmented into Yeast, Fungi and Bacteria. Based on Form, the market is segmented into Liquid and Dry. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Lactase Market is Predict to reach $355.2 Million by 2028, at a CAGR of 6.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
By Application
By Source
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 